A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia
Completed · Phase 3 · Has a placebo group
Conditions studied: Friedreich's Ataxia
In brief
The purpose of this study is to assess the Efficacy, Long Term Safety and Tolerability of RT001 in subjects with Friedreich's Ataxia
Key facts
- Study ID
- NCT04102501
- Run by
- Biojiva LLC
- People needed
- 65
- Starts
- 2019-10-30
- Expected to finish
- 2021-08-23
- Last updated by the study team
- 2022-05-27
Who can join
Age: 12 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Collaborative Neuroscience Network, LLC — Long Beach, California, United States
- UCLA — Los Angeles, California, United States
- University of Florida — Gainesville, Florida, United States
- USF Ataxia Research Center — Tampa, Florida, United States
- University of Iowa Stead Family Children's Hospital — Iowa City, Iowa, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.